Citius Pharmaceuticals Inc (CTXR) 0.6400 $CTXR Citius

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Citius Pharmaceuticals Inc (CTXR) 0.6400 $CTXR

Citius Pharmaceuticals to Present at the 2016 Aegis Growth Conference
PR Newswire - Mon Sep 19, 6:00AM CDT
Citius Pharmaceuticals, Inc. ("Citius" (OTC BB: CTXR), a specialty pharmaceutical company dedicated to developing and commercializing adjunctive cancer care and critical care drug products, announced today that its President and CEO, Myron Holubiak, will present at the 2016 Aegis Growth Conference. The Conference will be held on September 20-22, 2016 at the Encore at Wynn Las Vegas.

Citius Initiates Mino-Lok(TM) Phase 3 Trial
PR Newswire - Tue Sep 13, 6:00AM CDT
Citius Pharmaceuticals, Inc. ("Citius" (OTC BB: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced today that it has initiated the pivotal Phase 3 clinical trial Mino-Lok(TM), an antibiotic lock solution used to salvage infected central venous catheters (CVCs) and to treat catheter related bloodstream infections (CRBSIs).
MEDP: 30.44 (-0.13)

Citius Pharmaceuticals, Inc., Initiates Manufacturing of Mino-Lok(TM)
PR Newswire - Thu Sep 08, 6:00AM CDT
Citius Pharmaceuticals, Inc. ("Citius" (OTC QB: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced today that it has initiated manufacturing for the company's clinical trial of Mino-Lok (TM), an antibiotic lock solution used to salvage central venous catheters (CVCs) and to treat catheter related bloodstream infections (CRBSIs).

Citius Pharmaceuticals to Present at the Rodman & Renshaw 18th Annual Global Investment Conference
PR Newswire - Wed Sep 07, 9:32AM CDT
Citius Pharmaceuticals, Inc. ("Citius" (OTC QB: CTXR), a specialty pharmaceutical company dedicated to developing and commercializing adjunctive cancer care and critical care drug products, announced today that its Chairman, Len Mazur, will present at the Rodman & Renshaw 18th Annual Global Investment Conference. The Conference will be held on September 11-13, 2016 at the Lotte New York Palace Hotel, New York City.

Citius Announces Completion of In-Depth Interviews on Patient-Reported Outcomes: Signs and Symptoms of Hemorrhoids and Treatments
CNW Group - Tue Aug 23, 12:55PM CDT
Leading Life Sciences Market Research Firm Conducted Patient Interviews

Looking for "Firsts" in Health Care? Check Out Upcoming Catalysts for Citius Pharmaceuticals
PR Newswire - Thu Aug 04, 9:13AM CDT
By Sara Bowman, Senior Staff Writer, Online Media Group, Inc.

Citius Pharmaceuticals Provides Shareholder Update on Recent Achievements
PR Newswire - Mon Aug 01, 6:00AM CDT
Citius Pharmaceuticals, Inc. ("Citius" (OTC BB: CTXR), a specialty pharmaceutical company dedicated to developing and commercializing adjunctive cancer care and critical care drug products, today provided shareholders with an update regarding the company's recent more notable achievements.

OTCQX and OTCQB Companies to Present at 2016 Marcum MicroCap Conference
PR Newswire - Tue May 31, 5:49PM CDT
OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the lineup of OTCQX® Best and OTCQB® Venture Market companies presenting at the Marcum MicroCap Conference, taking place June 1-2nd at the Grand Hyatt New York. The Marcum MicroCap Conference, is dedicated to providing a forum where publicly traded companies with less than $500 million in market capitalization can network with the investment community. The Conference will feature presentations by CEOs and CFOs from various industry sectors, expert panels, and the opportunity to meet with management of presenting companies on a one-on-one basis.
LTEA: 4.90 (-0.10)

Citius Pharmaceuticals Announces Results from Phase 2a Trial of Hydrocortisone and Lidocaine Combination Cream in Patients with Grade I and II Hemorrhoids
PR Newswire - Mon Feb 01, 6:00AM CST
Citius Pharmaceuticals, Inc. (OTCQB: CTXR) today announced top line data from the first Phase 2a clinical trial of hydrocortisone acetate (HC) and lidocaine hydrochloride (L) as single agents and in combination (HC+L) in patients with grade I and II hemorrhoids. Citius' hydrocortisone and lidocaine cream is targeting to become the first FDA -approved prescription product to treat hemorrhoids in the U.S.

Citius Pharmaceuticals, Inc. Announces Appointment of Mr. Suren Dutia to Its Board of Directors
PR Newswire - Thu Oct 08, 6:00AM CDT
Citius Pharmaceuticals, Inc. (OTCQB: CTXR), (the "Company" announced today that it has appointed Mr. Suren Dutia to the board of directors effective October 8, 2015.

Citius Pharmaceuticals Announces Myron Holubiak, Former President of Roche Laboratories, Inc., USA, has Joined Its Board of Directors
PR Newswire - Tue Oct 06, 6:00AM CDT
Citius Pharmaceuticals, Inc. (OTCQB: CTXR), (the "Company" announced today that it has appointed Mr. Myron Holubiak to the board of directors effective October 1, 2015.
BIOS: 2.87 (-0.05), ASMB: 7.32 (+0.16)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading

Top 5 Most Recently Viewed Articles

Pasinex Resources Strengthens Leadership and Strategic Direction

Updated Category News Views 129

Pasinex Resources Limited's Leadership Revamp Pasinex Resources Limited, a prominent Canadian mining company focused on maximizing opportunities in the high-grade zinc-lead-silver sector, recently announced significant leadership changes. This initiative is aimed at enhancing its operational efficiency and positioning the company for sustainable growth in the...

Continue Reading
Reitar Logtech Ventures into Strategic Partnership with Solowin

Updated Category News Views 106

Strategic Partnership Announcement Reitar Logtech Holdings Limited (NASDAQ: RITR), a prominent integrated Property-Logistics Technology (PLT) solutions platform in Asia, is excited to share its latest strategic partnership with Solowin Holdings (NASDAQ: SWIN). This partnership marks a significant step towards transforming the logistics landscape through innovative...

Continue Reading
Brandon Ciaccio Appointed as Grasons' Brand President

Updated Category News Views 217

Brandon Ciaccio Takes the Helm as Grasons Brand President Grasons, a premier franchise brand in the estate sales and business liquidation sector, has announced a significant leadership change. Brandon Ciaccio has been appointed as the new Brand President, a move that brings extensive experience in operational growth and leadership to the company. Previously, Ciaccio...

Continue Reading
Exploring the Impact of AI, 5G, and IoT on Payments Today

Updated Category News Views 127

Transformative Technologies Shaping Payment Experiences In an era where technology is at the forefront of commerce, the advances in AI, 5G, and IoT play a pivotal role in redefining how transactions are conducted. The U.S. Payments Forum has recently published a comprehensive white paper titled "Contextual Payments Considering Artificial Intelligence, 5G, and Internet of...

Continue Reading
Chicory Market Expected to Surge to USD 1.4 Billion Soon

Updated Category News Views 63

Understanding the Chicory Market and Its Growth Potential Chicory (Cichorium intybus L.) is a perennial herb that has gained international recognition due to its adaptability and health benefits. This remarkable plant, native to Europe, thrives in various climates worldwide, from northern Africa to the eastern United States and Australia. With a variety of uses, chicory...

Continue Reading